Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and commercialize next-generation PCVs for both ...

Anavex Life Sciences receives EMA filing acceptance for blarcamesine to review marketing authorization application to treat Alzheimer’s disease: New York Thursday, December 26, ...

The Parliamentary panel that looked into the budget allocation for the Department of Pharmaceuticals (DoP) and related matters has recommended to the government to enhance its existing incentives for ...

Peethaambaran Kunnathoor, Chennai Thursday, December 26, 2024, 08:00 Hrs [IST] ...

MedLern offers healthcare training in India with customized digital learning solutions: Deepak Sharma: Shardul Nautiyal, Mumbai Thursday, December 26, 2024, 08:00 Hrs [IST] MedLer ...

In a move to curb unethical promotional practices in the pharma sector after the introduction of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), the Apex Committee for Pharma ...

Indian pharma adopts Patient-Centric Pharmaceutical Product Design to improve medication adherence: Nandita Vijayasimha, Bengaluru Thursday, December 26, 2024, 08:00 Hrs [IST] Ind ...

Indian pharma looks to adopt flexible label printing solutions for personalized medicine needs: Nandita Vijayasimha, Bengaluru Thursday, December 26, 2024, 08:00 Hrs [IST] Indian ...

Ramesh Shankar Wednesday, December 25, 2024, 08:00 Hrs [IST] The Karnataka State Registered Pharmacists Organization has recently brought to the notice of ...

Idorsia Ltd has provided an update on the ongoing exclusive negotiations for the global rights to aprocitentan. On November 27, 2024, the company announced that it had entered exclusive negotiations ...

Aethlon Medical updates ability of its medical device ‘Hemopurifier’ to capture H5N1 Bird Flu: San Diego Tuesday, December 24, 2024, 18:00 Hrs [IST] Aethlon Medical, Inc, a me ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation for the medicine givinostat (Duvyzat) of Italfarmaco to treat Duchenne muscular ...